Itron announced a $700 million private offering of convertible senior notes due 2032, increasing from $600 million.
Quiver AI Summary
Itron, Inc. announced the pricing of its private offering of $700 million in 0.00% convertible senior notes due in 2032, increasing from an initial offering of $600 million. The offering will settle on February 26, 2026, and includes an option for initial purchasers to buy an additional $105 million in notes. The conversion price is set at approximately $123.77 per share, reflecting a 30% premium over the stock's last price. The company plans to use the proceeds for stock repurchases, capped call transactions to mitigate dilution, and general corporate purposes, including repaying existing convertible notes. The notes are being offered under Rule 144A and are not registered under the Securities Act, limiting their sale in the U.S. without registration.
Potential Positives
- The offering size was increased from $600 million to $700 million, indicating strong demand for the Notes.
- Net proceeds from the offering are estimated to be approximately $681.1 million, which the company plans to use for stock repurchases and debt repayment, potentially enhancing its financial position.
- The conversion premium of approximately 30% over the last reported sale price of the common stock may indicate investor confidence in future growth.
- The company entered into capped call transactions that are expected to reduce potential dilution of its common stock upon conversion of the Notes, which is a proactive step to maintain shareholder value.
Potential Negatives
- Increasing the offering size of the convertible senior notes from $600 million to $700 million may indicate a heightened need for capital, which could raise concerns about the company's financial health.
- The notes will not bear regular interest and have a conversion premium of approximately 30%, which suggests potential dilution of existing shareholders' equity if the company's stock price does not improve adequately.
- The reliance on convertible notes and potential dilution associated with them can create uncertainty for investors regarding future equity value and shareholder returns.
FAQ
What is the total amount of Itron's private offering of convertible senior notes?
Itron's private offering totals $700.0 million in aggregate principal amount of convertible senior notes.
What is the maturity date of Itron's convertible senior notes?
The convertible senior notes will mature on March 15, 2032, unless converted or redeemed earlier.
What is the initial conversion price for the convertible notes?
The initial conversion price is approximately $123.77 per share, with a conversion premium of about 30.0%.
How will Itron use the proceeds from the convertible notes offering?
Itron plans to use proceeds for stock repurchase, capped call transactions, debt repayment, and general corporate purposes.
Are the convertible senior notes registered under the Securities Act?
No, the convertible senior notes have not been registered and may not be offered or sold without registration or exemption.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$ITRI Insider Trading Activity
$ITRI insiders have traded $ITRI stock on the open market 26 times in the past 6 months. Of those trades, 0 have been purchases and 26 have been sales.
Here’s a breakdown of recent trading of $ITRI stock by insiders over the last 6 months:
- THOMAS DEITRICH (President & CEO) has made 0 purchases and 3 sales selling 60,906 shares for an estimated $6,059,107.
- JOAN S HOOPER (SVP & CFO) has made 0 purchases and 3 sales selling 17,667 shares for an estimated $1,756,567.
- JOHN F. MARCOLINI (SVP, Networked Solutions) has made 0 purchases and 3 sales selling 8,575 shares for an estimated $852,540.
- DONALD L. III REEVES (SVP, Outcomes) has made 0 purchases and 5 sales selling 7,552 shares for an estimated $749,237.
- JUSTIN K PATRICK (SVP, Device Solutions) has made 0 purchases and 3 sales selling 6,137 shares for an estimated $610,238.
- CHRISTOPHER E. WARE (SVP, GC & Corp. Secretary) has made 0 purchases and 3 sales selling 5,592 shares for an estimated $556,058.
- LAURIE ANN PULATIE-HAHN (SVP, HR) has made 0 purchases and 4 sales selling 4,734 shares for an estimated $472,158.
- DAVID MARSHALL WRIGHT (VP, Corp. Controller & CAO) has made 0 purchases and 2 sales selling 368 shares for an estimated $36,480.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ITRI Revenue
$ITRI had revenues of $571.7M in Q4 2025. This is a decrease of -6.72% from the same period in the prior year.
You can track ITRI financials on Quiver Quantitative's ITRI stock page.
$ITRI Hedge Fund Activity
We have seen 194 institutional investors add shares of $ITRI stock to their portfolio, and 299 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,387,292 shares (-83.0%) from their portfolio in Q4 2025, for an estimated $128,823,935
- MACQUARIE GROUP LTD removed 764,826 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $71,021,742
- HANDELSBANKEN FONDER AB removed 654,711 shares (-65.5%) from their portfolio in Q4 2025, for an estimated $60,796,463
- JPMORGAN CHASE & CO removed 553,146 shares (-81.9%) from their portfolio in Q4 2025, for an estimated $51,365,137
- GOLDMAN SACHS GROUP INC removed 441,197 shares (-43.8%) from their portfolio in Q4 2025, for an estimated $40,969,553
- BNP PARIBAS FINANCIAL MARKETS removed 378,208 shares (-60.9%) from their portfolio in Q4 2025, for an estimated $35,120,394
- SOROS FUND MANAGEMENT LLC added 375,219 shares (+inf%) to their portfolio in Q4 2025, for an estimated $34,842,836
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ITRI Analyst Ratings
Wall Street analysts have issued reports on $ITRI in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Baird issued a "Outperform" rating on 02/18/2026
- JP Morgan issued a "Overweight" rating on 10/16/2025
To track analyst ratings and price targets for $ITRI, check out Quiver Quantitative's $ITRI forecast page.
$ITRI Price Targets
Multiple analysts have issued price targets for $ITRI recently. We have seen 5 analysts offer price targets for $ITRI in the last 6 months, with a median target of $130.0.
Here are some recent targets:
- Noah Kaye from Oppenheimer set a target price of $133.0 on 02/18/2026
- Ben Kallo from Baird set a target price of $128.0 on 02/18/2026
- Martin Malloy from Johnson Rice set a target price of $130.0 on 01/05/2026
- Mark Strouse from JP Morgan set a target price of $155.0 on 10/16/2025
- Tommy Moll from Stephens & Co. set a target price of $130.0 on 10/07/2025
Full Release
LIBERTY LAKE, Wash., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Itron, Inc. (NASDAQ: ITRI) (the “Company”), which is innovating new ways for utilities and cities to manage energy and water, today announced the pricing of its private offering of $700.0 million aggregate principal amount of its 0.00% convertible senior notes due 2032 (the “Notes”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering size was increased from the previously announced offering size of $600.0 million aggregate principal amount of Notes. The Company also granted the initial purchasers of the Notes an option to purchase, for settlement during a 13-day period beginning on, and including the first day the Notes are issued, an additional $105.0 million aggregate principal amount of Notes. The offering is expected to settle on February 26, 2026, subject to customary closing conditions.
The Notes will not bear regular interest, and the principal amount of the Notes will not accrete. The Notes will mature on March 15, 2032, unless earlier converted, redeemed or repurchased. The conversion rate will initially be 8.0793 shares of common stock per $1,000 principal amount of Notes, subject to adjustment in certain circumstances. This represents an initial conversion price of approximately $123.77 per share, representing a conversion premium of approximately 30.0% over the last reported sale price of $95.21 per share of the Company’s common stock on February 23, 2026. The Notes will be convertible at the option of the holders prior to December 15, 2031 only during certain periods upon the occurrence of certain events and will be convertible thereafter at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. Upon conversion, the Company will pay cash up to the aggregate principal amount of Notes to be converted and pay and/or deliver, as the case may be, cash, shares of common stock or a combination of cash and shares of common stock, at its election, in respect of the remainder, if any, of its conversion obligation in excess of the aggregate principal amount of the Notes being converted.
In addition, the Notes will be redeemable, in whole or in part (subject to certain limitations), for cash at the Company’s option at any time, and from time to time, on or after March 20, 2030 and prior to December 15, 2031, but only if the last reported sale price per share of the Company’s common stock exceeds 130% of the conversion price for a specified period of time and certain other conditions are satisfied. If the Company undergoes a “fundamental change” (as defined in the indenture governing the Notes), holders of the Notes may require the Company to repurchase for cash all or any portion of their Notes at a repurchase price equal to 100% of the principal amount of the Notes to be repurchased, plus accrued and unpaid additional interest, if any, to, but excluding, the repurchase date. In addition, upon certain corporate events or upon redemption, the Company will, under certain circumstances, increase the conversion rate for holders who convert Notes in connection with such a corporate event or redemption.
In connection with the pricing of the Notes, the Company entered into privately negotiated capped call transactions with certain of the initial purchasers or their affiliates and other financial institutions (the “Capped Call Counterparties”). The capped call transactions are expected generally to reduce the potential dilution to the Company’s common stock upon any conversion of the Notes and/or offset the cash payments the Company is required to make in excess of the principal amount of converted Notes, as the case may be, in the event that the market price of the common stock is greater than the strike price of the capped call transactions, which initially corresponds to the initial conversion price of the relevant Notes. If, however, the market price per share of the Company’s common stock, as measured under the terms of the capped call transactions, exceeds the cap price of the capped call transactions, there would nevertheless be dilution and/or there would not be an offset of such potential cash payments, in each case, to the extent that such market price exceeds the cap price of the capped call transactions. The cap price of the capped call transactions will initially be $190.42 per share and is subject to certain adjustments under the terms of the capped call transactions. If the initial purchasers exercise their option to purchase additional Notes, the Company may enter into additional capped call transactions with the Capped Call Counterparties.
The Company expects that, in connection with establishing their initial hedge of the capped call transactions, the Capped Call Counterparties or their respective affiliates may enter into various derivative transactions with respect to the common stock concurrently with, or shortly after, the pricing of the Notes, and may unwind these various derivative transactions and purchase shares of common stock in open market transactions shortly after the pricing of the Notes. These activities could increase (or reduce the size of any decrease in) the market price of the common stock or the Notes at that time. In addition, the Company expects that the Capped Call Counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding derivative transactions with respect to the common stock and/or by purchasing or selling shares of the common stock or other securities of the Company in secondary market transactions following the pricing of the Notes and prior to the maturity date of the Notes (and (i) are likely to do so during any observation period related to a conversion of Notes or following redemption of the Notes by the Company or following any repurchase of the Notes by the Company in connection with any fundamental change and (ii) are likely to do so following any repurchase of the Notes by the Company other than in connection with any such redemption or fundamental change if the Company elects to unwind a corresponding portion of the capped call transactions in connection with such repurchase). This activity could also cause or avoid an increase or a decrease in the market price of the common stock or the Notes, which could affect the ability of noteholders to convert the Notes and, to the extent the activity occurs during any observation period related to a conversion of the Notes, could affect the amount and value of the consideration that noteholders will receive upon conversion of the Notes.
The Company estimates that the net proceeds from the offering of Notes will be approximately $681.1 million (or approximately $783.3 million if the initial purchasers exercise their option to purchase additional Notes in full), after deducting the initial purchasers’ discounts and commissions and estimated offering expenses payable by the Company. The Company expects to use approximately $80.7 million of the net proceeds from the offering of Notes to pay the cost of the capped call transactions described above. The Company also intends to use approximately $100.0 million of the net proceeds from the offering to repurchase 1,050,309 shares of its common stock concurrently with the pricing of the offering of Notes in privately negotiated transactions effected through one of the initial purchasers of the Notes or its affiliate, as the Company’s agent, which could increase (or reduce the size of any decrease in) the market price of the common stock at that time. The Company intends to use the remainder of the proceeds for the repayment of the Company’s 0.00% Convertible Senior Notes due 2026, and for general corporate purposes. If the initial purchasers of the Notes exercise their option to purchase additional Notes, the Company may use a portion of the net proceeds from the sale of the additional Notes to enter into additional capped call transactions relating to the Notes. The Company intends to use the remainder of the additional net proceeds, if any, for general corporate purposes.
The Notes will be offered to persons reasonably believed to be qualified institutional buyers in accordance with Rule 144A under the Securities Act. The Notes have not been, and will not be, registered under the Securities Act, or the securities laws of any state or other jurisdiction, and, unless so registered, may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
This press release does not constitute an offer to sell or a solicitation of an offer to buy the Notes and shall not constitute an offer, solicitation or sale in any jurisdiction in which such an offer, solicitation or sale would be unlawful prior to the registration and qualification under the securities laws of such state or jurisdiction.
About Itron
Itron is a proven global leader in energy, water, smart city, IIoT and intelligent infrastructure services. For utilities, cities and society, we build innovative systems, create new efficiencies, connect communities, encourage conservation and increase resourcefulness. By safeguarding our invaluable natural resources today and tomorrow, we improve the quality of life for people around the world.
Itron® and the Itron Logo are registered trademarks of Itron, Inc. in the United States and other countries and regions. All third-party trademarks are property of their respective owners, and any usage herein does not suggest or imply any relationship between Itron and the third party unless expressly stated.
Cautionary Note Regarding Forward Looking Statements
This release contains, and our officers and representatives may from time to time make, "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are neither historical factors nor assurances of future performance. These statements are based on our expectations about, among others, revenues, operations, financial performance, earnings, liquidity, earnings per share, cash flows and restructuring activities including headcount reductions and other cost savings initiatives. This document reflects our current strategy, plans and expectations and is based on information currently available as of the date of this release. When we use words such as "expect", "intend", "anticipate", "believe", "plan", "goal", "seek", "project", "estimate", "future", "strategy", "objective", "may", "likely", "should", "will", "will continue", and similar expressions, including related to future periods, they are intended to identify forward-looking statements. Forward-looking statements rely on a number of assumptions and estimates. Although we believe the estimates and assumptions upon which these forward-looking statements are based are reasonable, any of these estimates or assumptions could prove to be inaccurate and the forward-looking statements based on these estimates and assumptions could be incorrect. Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Actual results and trends in the future may differ materially from those suggested or implied by the forward-looking statements depending on a variety of factors. Therefore, you should not rely on any of these forward-looking statements. Some of the factors that we believe could affect our results include our ability to execute on our restructuring plans, our ability to achieve estimated cost savings, the rate and timing of customer demand for our products, rescheduling of current customer orders, changes in estimated liabilities for product warranties, adverse impacts of litigation, changes in laws, regulations, tariffs, sanctions, trade policies and retaliatory responses, our dependence on new product development and intellectual property, future acquisitions, changes in estimates for stock-based and bonus compensation, increasing volatility in foreign exchange rates, international business risks, uncertainties caused by adverse economic conditions, including without limitation those resulting from extraordinary events or circumstances and other factors that are more fully described in Part I, Item 1A: Risk Factors included in our Annual Report on Form 10-K for the year ended Dec. 31, 2025 and other reports on file with the Securities and Exchange Commission. Itron undertakes no obligation to update or revise any information in this press release.
For additional information, contact:
Itron, Inc.
Paul Vincent
Vice President, Investor Relations
512-560-1172
[email protected]